Potential Savings from Greater Use of $4 Generic Drugs

Published In: Archives of Internal Medicine, v. 171, no. 5, Mar. 2011, p. 468-469

Posted on RAND.org on March 01, 2011

by Yuting Zhang, Lei Zhou, Walid F. Gellad

Read More

Access further information on this document at The American Medical Association

This article was published outside of RAND. The full text of the article can be found at the link above.

Discounted generic medication programs ($4 per 30-day supply or $10 per 90-day supply) are available at pharmacies of many retail stores, such as Wal-Mart and Target. Patients pay only $4 for qualifying generic drugs through these programs, regardless of the type of insurance they have. Use of $4 programs could potentially save patients and society billions of dollars. This paper presents findings from a study evaluating who may be using $4 programs and identifying potential national savings from broad use of these programs.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.